Passed: Validates the formulations acid/base balance to support comfortable administration
When you take semaglutide, it can sometimes be recognized by your body as a foreign substance
however, there are shortcomings in implementing patient education, multidisciplinary collaboration, and psychological interventions
Nausea affects 25-44% of patients, while diarrhea occurs in 19-30% and vomiting in 8-24% of users
Dosage and Timing: The recommended dose (for approved uses) is delivered via an auto-injector about 45 minutes to an hour before anticipated sexual activity
doi: 10.1111/1753-0407.12891 Summary Keywords diabetic kidney disease, diabetic nephropathy, GLP-1 receptor agonists, liraglutide, semaglutide, dulaglutide Citation Kawanami D and Takashi Y (2020) GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms